Abstract
The guest editors of the June 2016 special issue of the Journal of Biomolecular Screening (Vol. 21, No. 5) (JBS) on “Innovative Screening Methodologies to Identify New Compounds for the Treatment of Central Nervous System Disorders” were not acknowledged in the final published issue. JBS gratefully thanks Drs. Kevin Burris and Steven Dworetzky for their valued contributions and apologizes for the oversight. (Original DOI:
